Login / Signup

Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.

Elena RicciardiElena GiordaniGiovanna ZicchedduItalia FalconePatrizio GiacominiMaurizio FanciulliMichelangelo RussilloMarianna CerroGennaro CilibertoAldo MorroneAntonino GuerrisiFabio Valenti
Published in: International journal of molecular sciences (2023)
Precision medicine has driven a major change in the treatment of many forms of cancer. The discovery that each patient is different and each tumor mass has its own characteristics has shifted the focus of basic and clinical research to the singular individual. Liquid biopsy (LB), in this sense, presents new scenarios in personalized medicine through the study of molecules, factors, and tumor biomarkers in blood such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), exosomes and circulating tumor microRNAs (ct-miRNAs). Moreover, its easy application and complete absence of contraindications for the patient make this method applicable in a great many fields. Melanoma, given its highly heterogeneous characteristics, is a cancer form that could significantly benefit from the information linked to liquid biopsy, especially in the treatment management. In this review, we will focus our attention on the latest applications of liquid biopsy in metastatic melanoma and possible developments in the clinical setting.
Keyphrases